IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Immatics N.V.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026

$7.05+0.32 (+4.75%)

Close on Oct 19, 2026

Immatics N.V. revenue by segment

Immatics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.